FTC CHAIRMAN NOMINEE PITOFSKY'S SENATE CONFIRMATION MAY BE MORE DIFFICULT
This article was originally published in The Gray Sheet
Executive Summary
FTC CHAIRMAN NOMINEE PITOFSKY'S SENATE CONFIRMATION MAY BE MORE DIFFICULT in light of the Republican control of the Senate. President Clinton's Oct. 6 nomination of Robert Pitofsky -- a Washington, D.C. lawyer who served on the Federal Trade Commission in the Carter administration -- will likely face scrutiny from a Republican-controlled Senate inclined to minimize government oversight of business practices.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.